Injectable Drug Compatibility News
Summer 2026 - Injectable Drug Updates
We included new stability information to the monographs for: CEFTOBIPROLE MEDOCARIL SODIUM, CEFTAZIDIME, CEFTAZIDIME AND AVIBACTAM SODIUM, ERTAPENEM, MEROPENEM, NALBUPHINE HYDROCHLORIDE, and ORPHENADRINE CITRATE. Compatibility information was added to the monographs for ACYCLOVIR SODIUM, AMIKACIN SULFATE, AMOXICILLIN SODIUM, AMPHOTERICIN B, CEFOTAXIME SODIUM, CEFTRIAXONE SODIUM, CLONAZEPAM, DIAZEPAM, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, KETAMINE HYDROCHLORIDE, KETOPROFEN, KETOROLAC, METHADONE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, SODIUM BICARBONATE, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.
Spring 2026 - Injectable Drugs Update
In this update, we added a new monograph for TREOSULFAN. We included new stability information to the monograph for EPINEPHRINE HYDROCHLORIDE. Compatibility information was added for AMOXICILLIN/CLAVULANATE mixed with 49 different drugs; and a boxed warning was added to the monograph for TRANEXAMIC ACID.
Winter 2025
In this update we added a new monograph for AZTREONAM AND AVIBACTAM. We included new stability information to the monograph for AZTREONAM AND AVIBACTAM. Compatibility information was added for these drugs: ACETAMINOPHEN, AMIODARONE HYDROCHLORIDE, BUMETANIDE, CEFAZOLIN SODIUM, CEFOTAXIME SODIUM, CLONIDINE HYDROCHLORIDE, FUROSEMIDE, HEPARIN SODIUM, HYALURONIDASE, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, INSULIN, REGULAR, ISOSORBIDE DINITRATE, LEVETIRACETAM, LEVOFLOXACIN, MAGNESIUM SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, PANTOPRAZOLE SODIUM, PHLOROGLUCINOL, PHYTONADIONE, POTASSIUM CHLORIDE, PYRIDOXINE HYDROCHLORIDE, REMIFENTANIL, THIAMINE HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.
Fall 2025
New and updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.
Summer 2025
New & updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.